Huse Jason T
Department of Pathology, Memorial Sloan-Kettering Cancer Center, 408 East 69th Street (Z564), New York, NY 10065, USA.
Surg Pathol Clin. 2016 Sep;9(3):379-90. doi: 10.1016/j.path.2016.04.005.
The comprehensive molecular profiling of cancer has dramatically altered conceptions of numerous tumor types, particularly with regard to their fundamental classification. In the case of primary brain tumors, the widespread use of disease-defining biomarker sets is profoundly reshaping existing diagnostic entities that had been designated solely by histopathological criteria for decades. This review describes recent progress for diffusely infiltrating gliomas of adulthood, the most common primary brain tumor variants. More specifically, it details how routine incorporation of a handful of highly prevalent molecular alterations robustly designates refined subclasses of glioma that transcend conventional histopathological designations.
癌症的全面分子剖析极大地改变了对多种肿瘤类型的认识,尤其是在其基本分类方面。就原发性脑肿瘤而言,定义疾病的生物标志物组的广泛应用正在深刻重塑现有的诊断实体,这些实体几十年来一直仅由组织病理学标准来指定。本综述描述了成人弥漫性浸润性胶质瘤(最常见的原发性脑肿瘤变体)的最新进展。更具体地说,它详细介绍了如何通过常规纳入一些高度普遍的分子改变来有力地指定超越传统组织病理学分类的胶质瘤精细亚类。